BEHAVIORAL ALTERATIONS WITH END-OF-DOSE DETERIORATION IN PARKINSONS-DISEASE

被引：0
|
作者：
FREIDENBERG, DL
HUBER, SJ
POWELL, S
LEE, D
机构：
来源：
ANNALS OF NEUROLOGY | 1989年 / 26卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：126 / 126
页数：1
相关论文
共 50 条
  • [1] END-OF-DOSE DYSTONIA IN PARKINSONS-DISEASE
    BRAVI, D
    MOURADIAN, MM
    ROBERTS, JW
    DAVIS, TL
    CHASE, TN
    NEUROLOGY, 1993, 43 (10) : 2130 - 2131
  • [2] MOOD CHANGES ASSOCIATED WITH END-OF-DOSE DETERIORATION IN PARKINSONS-DISEASE - A CONTROLLED-STUDY
    CANTELLO, R
    GILLI, M
    RICCIO, A
    BERGAMASCO, B
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1986, 49 (10): : 1182 - 1190
  • [3] BROMOCRIPTINE IN THE MANAGEMENT OF END OF DOSE DETERIORATION IN PARKINSONS-DISEASE
    GRIMES, JD
    KING, DB
    KOFMAN, OS
    MOLINANEGRO, P
    WILSON, AF
    BOUCHARD, S
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1984, 11 (04) : 452 - 456
  • [4] FLUCTUATION OF ARTERIAL BLOOD-PRESSURE DURING END-OF-DOSE AKINESIA IN PARKINSONS-DISEASE
    BARATTI, M
    CALZETTI, S
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1984, 47 (11): : 1241 - 1243
  • [5] TOLCAPONE IMPROVES MOTOR FUNCTION AND REDUCES LEVODOPA REQUIREMENT IN PATIENTS WITH PARKINSONS-DISEASE (PD) EXPERIENCING END-OF-DOSE MOTOR FLUCTUATIONS
    KURTH, MC
    ADLER, CH
    STHILAIRE, M
    SINGER, C
    WATERS, C
    CHERNIK, DA
    DORFLINGER, E
    YOO, K
    DAVIS, T
    HOEHN, M
    LEWITT, P
    MONTGOMERY, E
    MUENTER, M
    TANNER, C
    TRUGMAN, J
    NEUROLOGY, 1995, 45 (04) : A275 - A276
  • [6] NEUROTRANSMITTER RECEPTOR ALTERATIONS IN PARKINSONS-DISEASE
    REISINE, TD
    FIELDS, JZ
    YAMAMURA, HI
    BIRD, ED
    SPOKES, E
    SCHREINER, PS
    ENNA, SJ
    LIFE SCIENCES, 1977, 21 (03) : 335 - 343
  • [7] End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson's disease
    Thomas, Astrid
    Bonanni, Laura
    Di Iorio, Angelo
    Varanese, Sara
    Anzellotti, Francesca
    D'Andreagiovanni, Anna
    Stocchi, Fabrizio
    Onofrj, Marco
    JOURNAL OF NEUROLOGY, 2006, 253 (12) : 1633 - 1639
  • [8] FRONTAL AND VISUOSPATIAL ALTERATIONS IN PARKINSONS-DISEASE
    VICENTE, MJ
    PLAJA, CJ
    ARCHIVOS DE NEUROBIOLOGIA, 1994, 57 (04): : 177 - 184
  • [9] End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson’s disease
    Astrid Thomas
    Laura Bonanni
    Angelo Di Iorio
    Sara Varanese
    Francesca Anzellotti
    Anna D’Andreagiovanni
    Fabrizio Stocchi
    Marco Onofrj
    Journal of Neurology, 2006, 253 : 1633 - 1639
  • [10] End-of-dose deterioration in non ergolinic doparnine agonist monotherapy of Parkinson's disease
    Onofrj, M
    Thomas, A
    Di lorio, A
    Bonanni, L
    Stocchi, F
    MOVEMENT DISORDERS, 2006, 21 : S89 - S89
12345